AMAG Pharmaceuticals Inc (AMAG)
16.76
-0.23 -1.35%
NASDAQ
Dec 14, 16:59
Delayed 2m
USD
View All Key Stats
AMAG Key Stats
| Income Statement | |
| Revenue (TTM) | 657.55M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.19 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -40.02M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 61.97% |
| Profit Margin (Quarterly) | 25.23% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 578.82M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.8781 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.7594 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -0.595M |
| Return on Equity (TTM) | Upgrade |
View All AMAG News
AMAG News
-
WireHeadlineTime (ET)
-
Yahoo12/14 10:25
-
MT Newswires12/13 07:07
-
SA Breaking News12/13 06:45
-
Globe Newswire12/13 06:30
-
Yahoo12/04 12:06
-
Globe Newswire12/03 08:00
-
Yahoo12/03 08:00
-
Yahoo11/29 12:50
-
Globe Newswire11/29 08:00
-
Yahoo11/26 17:37
View All Events
AMAG Events
| Date | Type | Description |
|---|---|---|
| 02/27/2019 08:00 EST | Misc | AMAG Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018 |
| 02/27/2019 | Earnings | AMAG Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release |
| 11/01/2018 08:00 EDT | Misc | AMAG Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018 |
| 11/01/2018 | Earnings | AMAG Pharmaceuticals Inc Third Quarter Earnings Results in 2018 |
| 08/02/2018 08:00 EDT | Misc | AMAG Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018 |
| 08/02/2018 | Earnings | AMAG Pharmaceuticals Inc Second Quarter Earnings Results in 2018 |
| 06/07/2018 | Misc | AMAG Pharmaceuticals Inc Annual General Meeting in 2017 |
| 05/03/2018 08:00 EDT | Misc | AMAG Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/03/2018 | Earnings | AMAG Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 03/01/2018 | Misc | AMAG Pharmaceuticals Inc Annual Report in 2017 |
AMAG Fundamentals
Income Statement View Statement
AMAG Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
AMAG One Page Reports
- One Page Report Download
AMAG Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 16.76 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.amagpharma.com
- Investor Relations URL: http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Feb. 27, 2019
- Last Earnings Release: Nov. 01, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.
AMAG Excel Add-In Codes
- Name: =YCI("AMAG","name")
- Description: =YCI("AMAG","description")
- Sector: =YCI("AMAG","sector")
- Industry: =YCI("AMAG","industry")
- Est. Current Fiscal Year End: =YCI("AMAG","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other AMAG Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- AMAG Tweets Stocktwits
Advertisement
